HABIT
发表于 2025-3-21 19:43:47
书目名称Ovarian Cancers影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0705205<br><br> <br><br>书目名称Ovarian Cancers影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0705205<br><br> <br><br>书目名称Ovarian Cancers网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0705205<br><br> <br><br>书目名称Ovarian Cancers网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0705205<br><br> <br><br>书目名称Ovarian Cancers被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0705205<br><br> <br><br>书目名称Ovarian Cancers被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0705205<br><br> <br><br>书目名称Ovarian Cancers年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0705205<br><br> <br><br>书目名称Ovarian Cancers年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0705205<br><br> <br><br>书目名称Ovarian Cancers读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0705205<br><br> <br><br>书目名称Ovarian Cancers读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0705205<br><br> <br><br>
moratorium
发表于 2025-3-21 22:49:06
http://image.papertrans.cn/o/image/705205.jpg
Pelvic-Floor
发表于 2025-3-22 01:04:42
https://doi.org/10.1007/978-3-319-32110-3Cancer therapeutics; Clinical research; Onco-fertility; Ovarian rare cancers; Quality of Life; surgical o
序曲
发表于 2025-3-22 07:39:29
Clear Cell CarcinomaClear cell carcinoma (CCC) is a unique entity of adenocarcinoma of the ovary. In this chapter, we discuss the clinicopathological and molecular biological characteristics of CCC. The results of clinical trials conducted in the past strongly imply the chemoresistance of CCC, and clinical trials using targeted agents are ongoing.
amplitude
发表于 2025-3-22 09:57:14
http://reply.papertrans.cn/71/7053/705205/705205_5.png
Myofibrils
发表于 2025-3-22 15:50:32
http://reply.papertrans.cn/71/7053/705205/705205_6.png
Carcinoma
发表于 2025-3-22 19:39:59
http://reply.papertrans.cn/71/7053/705205/705205_7.png
微生物
发表于 2025-3-22 22:20:55
Ovarian Cancer and HIPEC: In the Era of Evidence Based Medicineatment of advanced ovarian cancer..HIPEC is an innovative treatment. Before using it outside clinical trials in the case of initial treatment of advanced ovarian cancer, or in the case of the first relapse, results of large multi-institutionnal randomised trials built to assess impact on survival, are required.
残忍
发表于 2025-3-23 04:18:17
http://reply.papertrans.cn/71/7053/705205/705205_9.png
FLAIL
发表于 2025-3-23 08:05:13
How to Evaluate Tumor Burden Before Therapeutic Decision serum markers, and disease extension. Here we describe more advanced techniques to assess pre-operative tumor burden, ongoing clinical trials and integrated clinical models to individualize therapeutic decision.